This brand name is authorized in Estonia, Lithuania
The drug DOXALFA contains one active pharmaceutical ingredient (API):
|
1
Doxazosin
UNII 86P6PQK0MU - DOXAZOSIN MESYLATE
|
|
Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C02CA04 | Doxazosin | C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1205873, 1205884, 1205895, 1205907, 1205918, 1205929, 1205930, 1205941, 1205952, 1205963, 1205974, 1831036 |
| Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1004816, 1021595, 1021596, 1021597, 1021598, 1021599, 1021600, 1021601, 1021602, 1021603, 1021604, 1062601, 1062602, 1062603, 1091817 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
